Skip to main content
Top
Published in: Clinical Rheumatology 9/2015

01-09-2015 | Original Article

Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism is not a risk factor for hypertension in SLE nephritis

Authors: Vir S. Negi, Panneer Devaraju, Reena Gulati

Published in: Clinical Rheumatology | Issue 9/2015

Login to get access

Abstract

SLE is a systemic autoimmune disease with high prevalence of hypertension. Around 40–75 % of SLE patients develop nephritis, a major cause of hypertension and mortality. Angiotensin-converting enzyme (ACE) maintains the blood pressure and blood volume homeostasis. An insertion/deletion (I/D) polymorphism in intron 16 of ACE gene was reported to influence the development of hypertension, nephritis, and cardiovascular diseases in different ethnic populations. Despite compelling evidence for the high prevalence of hypertension in individuals with SLE, underlying factors for its development are not well studied. With this background, we analyzed the influence of ACE insertion/deletion polymorphism on susceptibility to SLE, development of nephritis and hypertension, other clinical features and autoantibody phenotype in South Indian SLE patients. Three hundred patients with SLE and 460 age and sex similar ethnicity matched individuals were included as patients and healthy controls, respectively. The ACE gene insertion/deletion polymorphism was analyzed by PCR. Insertion (I) and deletion (D) alleles were observed to be equally distributed among patients (57 and 43 %) and controls (59 and 41 %), respectively. The mutant (D) allele did not confer significant risk for SLE (II vs. ID: p = 0.4, OR 1.15, 95 % CI 0.8–1.6; II vs. DD: p = 0.34, OR 1.22, 95 % CI 0.8–1.85). There was no association of the ACE genotype or the allele with development of lupus nephritis (II vs. ID: p = 0.19, OR 1.41, 95 % CI 0.84–2.36; II vs. DD: p = 0.41, OR 0.74, 95 % CI 0.38–1.41) or hypertension (II vs. ID: p = 0.85, OR 0.9, 95 % CI 0.43–1.8; II vs. DD: p = 0.66, OR 1.217, 95 % CI 0.5–2.8). The presence of mutant allele (D) was not found to influence any clinical features or autoantibody phenotype. The insertion/deletion polymorphism of the ACE gene is not a genetic risk factor for SLE and does not influence development of hypertension or lupus nephritis in South Indian Tamils.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wakeland EK, Liu K, Graham RR, Behrens TW (2001) Delineating the genetic basis of SLE. Immunity 15:397–408CrossRefPubMed Wakeland EK, Liu K, Graham RR, Behrens TW (2001) Delineating the genetic basis of SLE. Immunity 15:397–408CrossRefPubMed
2.
go back to reference Canetta PA, Bomback AS, Radhakrishnan J (2011) Treating lupus in the kidney: where are we now, and where are we going? Discov Med 12:341–349PubMed Canetta PA, Bomback AS, Radhakrishnan J (2011) Treating lupus in the kidney: where are we now, and where are we going? Discov Med 12:341–349PubMed
3.
go back to reference Ramu P, Umamaheswaran G, Shewade DG, Swaminathan RP, Dutta TK, Balachander J, Adithan C (2011) Candidate gene polymorphisms of renin angiotensin system and essential hypertension in south Indian Tamilian population. Int J Hum Genet 11:31–40 Ramu P, Umamaheswaran G, Shewade DG, Swaminathan RP, Dutta TK, Balachander J, Adithan C (2011) Candidate gene polymorphisms of renin angiotensin system and essential hypertension in south Indian Tamilian population. Int J Hum Genet 11:31–40
4.
go back to reference Cambien F, Alhenc-Gelas F, Herbeth B, Andre JL, Rakotovao R, Gonzales MF, Allegrini J, Bloch C (1988) Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am J Hum Genet 43:774–780PubMedCentralPubMed Cambien F, Alhenc-Gelas F, Herbeth B, Andre JL, Rakotovao R, Gonzales MF, Allegrini J, Bloch C (1988) Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am J Hum Genet 43:774–780PubMedCentralPubMed
5.
go back to reference Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346PubMedCentralCrossRefPubMed Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343–1346PubMedCentralCrossRefPubMed
6.
go back to reference Tabatabaei FAS, Oostra BA, Isaacs AM, Van Duijn CM, Witteman JCM (2006) ACE polymorphisms. Circ Res 98:1123–1133CrossRef Tabatabaei FAS, Oostra BA, Isaacs AM, Van Duijn CM, Witteman JCM (2006) ACE polymorphisms. Circ Res 98:1123–1133CrossRef
8.
go back to reference Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRefPubMed Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725CrossRefPubMed
9.
go back to reference Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640CrossRefPubMed Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640CrossRefPubMed
10.
go back to reference Markowitz GS, D’Agati VD (2007) The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years. Kidney Int 71:491–495CrossRefPubMed Markowitz GS, D’Agati VD (2007) The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years. Kidney Int 71:491–495CrossRefPubMed
11.
go back to reference Chobanian AV, George LB, Henry RB et al (2003) The Seventh Report of the Joint National Committee on report prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560–2571CrossRefPubMed Chobanian AV, George LB, Henry RB et al (2003) The Seventh Report of the Joint National Committee on report prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560–2571CrossRefPubMed
12.
go back to reference Miller SA, Dykes DD, Polesky HF (1988) Simple salting out procedure for extracting DNA from human nucleated cells. Nuc Acids Res 16:1215CrossRef Miller SA, Dykes DD, Polesky HF (1988) Simple salting out procedure for extracting DNA from human nucleated cells. Nuc Acids Res 16:1215CrossRef
13.
go back to reference Patel M, Clarke AM, Bruce IN, Symmons DP (2006) The prevalence and incidence of biopsy-proven lupus nephritis in the UK: evidence of an ethnic gradient. Arthritis Rheum 54:2963–2969CrossRefPubMed Patel M, Clarke AM, Bruce IN, Symmons DP (2006) The prevalence and incidence of biopsy-proven lupus nephritis in the UK: evidence of an ethnic gradient. Arthritis Rheum 54:2963–2969CrossRefPubMed
14.
go back to reference Tassiulas IO, Aksentijevich I, Salmon JE, Kim Y, Yarboro CH, Vaughan EM et al (1998) Angiotensin I converting enzyme gene polymorphisms in systemic lupus erythematosus: decreased prevalence of DD genotype in African American patients. Clin Nephrol 50:8–13PubMed Tassiulas IO, Aksentijevich I, Salmon JE, Kim Y, Yarboro CH, Vaughan EM et al (1998) Angiotensin I converting enzyme gene polymorphisms in systemic lupus erythematosus: decreased prevalence of DD genotype in African American patients. Clin Nephrol 50:8–13PubMed
15.
go back to reference Malaviya AN, Chandrasekaran AN, Kumar A, Shamar PN (1997) Systemic lupus erythematosus in India. Lupus 6:690–700CrossRefPubMed Malaviya AN, Chandrasekaran AN, Kumar A, Shamar PN (1997) Systemic lupus erythematosus in India. Lupus 6:690–700CrossRefPubMed
16.
go back to reference Remuzzi G, Perico N, Macia M, And Ruggenenti P. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int 2005;68 9 (Suppl 99): pp. S57–S6 Remuzzi G, Perico N, Macia M, And Ruggenenti P. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int 2005;68 9 (Suppl 99): pp. S57–S6
17.
go back to reference Sprovieri SR, Sens YA (2005) Polymorphisms of the renin-angiotensin system genes in Brazilian patients with lupus nephropathy. Lupus 14:356–362CrossRefPubMed Sprovieri SR, Sens YA (2005) Polymorphisms of the renin-angiotensin system genes in Brazilian patients with lupus nephropathy. Lupus 14:356–362CrossRefPubMed
18.
go back to reference Molad Y, Gal E, Magal N, Sulkes J et al (2000) Renal outcome and vascular morbidity in systemic lupus erythematosus (SLE): lack of association with the angiotensin-converting enzyme gene polymorphism. Semin Arthritis Rheum 30:132–137CrossRefPubMed Molad Y, Gal E, Magal N, Sulkes J et al (2000) Renal outcome and vascular morbidity in systemic lupus erythematosus (SLE): lack of association with the angiotensin-converting enzyme gene polymorphism. Semin Arthritis Rheum 30:132–137CrossRefPubMed
19.
go back to reference Prkacin I, Novak B, Sertić J, Mrzljak A (2001) Angiotensin-converting enzyme gene polymorphism in patients with systemic lupus. Acta Med Croatica 55:73–76PubMed Prkacin I, Novak B, Sertić J, Mrzljak A (2001) Angiotensin-converting enzyme gene polymorphism in patients with systemic lupus. Acta Med Croatica 55:73–76PubMed
20.
go back to reference Akai Y, Sato H, Iwano M, Kurumatani N, Kurioka H, Kubo A et al (1999) Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of lupus nephritis. Clin Nephrol 51:141–146PubMed Akai Y, Sato H, Iwano M, Kurumatani N, Kurioka H, Kubo A et al (1999) Association of an insertion polymorphism of angiotensin-converting enzyme gene with the activity of lupus nephritis. Clin Nephrol 51:141–146PubMed
21.
go back to reference Zhou TB, Liu YG, Lin N, Qin YH, Huang K, Shao MB, Peng DD (2012) Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and systemic lupus erythematosus/lupus nephritis: a systematic review and metaanalysis. J Rheumatol 39:686–693CrossRefPubMed Zhou TB, Liu YG, Lin N, Qin YH, Huang K, Shao MB, Peng DD (2012) Relationship between angiotensin-converting enzyme insertion/deletion gene polymorphism and systemic lupus erythematosus/lupus nephritis: a systematic review and metaanalysis. J Rheumatol 39:686–693CrossRefPubMed
22.
go back to reference Topete-Reyes JF, SotoVargas J, Morán Moguel MC, Dávalos-Rodríguez (2013) Insertion/deletion polymorphism of the angiotensin-converting enzyme gene in lupus nephritis among Mexicans. Immunopharmacol Immunotoxicol 35:174–180CrossRefPubMed Topete-Reyes JF, SotoVargas J, Morán Moguel MC, Dávalos-Rodríguez (2013) Insertion/deletion polymorphism of the angiotensin-converting enzyme gene in lupus nephritis among Mexicans. Immunopharmacol Immunotoxicol 35:174–180CrossRefPubMed
23.
go back to reference Pullmann RJ, Lukac J, Skerenova M, Rovensky J, Hybenova J, Melus V et al (1999) Association between systemic lupus erythematosus and insertion/deletion polymorphism of the angiotensin converting enzyme (ACE) gene. Clin Exp Rheumatol 17:593–596PubMed Pullmann RJ, Lukac J, Skerenova M, Rovensky J, Hybenova J, Melus V et al (1999) Association between systemic lupus erythematosus and insertion/deletion polymorphism of the angiotensin converting enzyme (ACE) gene. Clin Exp Rheumatol 17:593–596PubMed
24.
go back to reference Uhm WS, Lee HS, Chung YH, Kim TH et al (2002) Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE. Lupus 11:227–233CrossRefPubMed Uhm WS, Lee HS, Chung YH, Kim TH et al (2002) Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE. Lupus 11:227–233CrossRefPubMed
Metadata
Title
Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism is not a risk factor for hypertension in SLE nephritis
Authors
Vir S. Negi
Panneer Devaraju
Reena Gulati
Publication date
01-09-2015
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 9/2015
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-2954-6

Other articles of this Issue 9/2015

Clinical Rheumatology 9/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine